Hyperion Defi (HYPD) Enterprise Value (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Enterprise Value of -$7.4 million for Q1 2026, down 87.34% year-over-year from -$58.5 million in Q1 2025, and down 14.85% quarter-over-quarter from -$6.4 million in Q4 2025.
Hyperion Defi (HYPD) Enterprise Value (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Enterprise Value for 10 consecutive years, with -$7.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 87.34% year-over-year to -$7.4 million; the TTM figure through Mar 2026 stood at -$7.4 million (down 87.34% YoY), while the FY2025 annual figure was -$6.4 million, down 201.6% from the prior year.
- Enterprise Value slipped to -$7.4 million in Q1 2026 per HYPD's latest filing, from -$6.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.1 million in Q4 2024 and bottomed at -$26.7 million in Q1 2022.
- Historically, Enterprise Value has averaged -$13.1 million across 5 years, with a median of -$8.4 million in 2025.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 86.85% — and 2025, when it tumbled 265.96%.
- Hyperion Defi's Enterprise Value stood at -$23.0 million in 2022, then jumped by 35.38% to -$14.9 million in 2023, then soared by 85.61% to -$2.1 million in 2024, then slumped by 201.6% to -$6.4 million in 2025, then declined by 14.85% to -$7.4 million in 2026.
- Business Quant data shows HYPD's Enterprise Value at -$7.4 million in Q1 2026, -$6.4 million in Q4 2025, and -$8.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | -9.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.64 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Dec 31, 2025 | -6.44 Mn |
| Sep 30, 2025 | -8.20 Mn |
| Jun 30, 2025 | -8.42 Mn |
| Mar 31, 2025 | -3.95 Mn |
| Dec 31, 2024 | -2.14 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Jun 30, 2024 | -2.30 Mn |
| Mar 31, 2024 | -7.98 Mn |
| Dec 31, 2023 | -14.85 Mn |
| Sep 30, 2023 | -20.70 Mn |
| Jun 30, 2023 | -17.50 Mn |
| Mar 31, 2023 | -18.62 Mn |
| Dec 31, 2022 | -22.98 Mn |
| Sep 30, 2022 | -25.27 Mn |
| Jun 30, 2022 | -21.51 Mn |
| Mar 31, 2022 | -26.72 Mn |
| Dec 31, 2021 | -27.34 Mn |
| Sep 30, 2021 | -13.50 Mn |